Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

8 Results Found

Advisory
Member

DEA and HHS Extend Waivers for Prescribing Controlled Substances Through Telemedicine

The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
Advisory
Member

CMS Issues Proposed Rule for CY 2027 Medicare Advantage, Prescription Drug Plans

The Centers for Medicare & Medicaid Services (CMS) Nov. 28 released its proposed Policy and Technical Changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program and Programs of All-Inclusive Care for the Elderly for Contract Year (CY) 2027.
Advisory
Member

CMS Releases Guidance on One Big Beautiful Bill Act Provisions on State-directed Payments

The CMS Sept. 9 issued preliminary guidance implementing section 71116 of the One Big Beautiful Bill Act (OBBBA).
Advisory
Member

UPDATED: Implications for Hospitals and Health Systems During a Government Shutdown

Over the past 15 days, the Senate has voted nine times on the House-passed continuing resolution (CR) to extend government funding and health care waivers until Nov. 21.
Advisory
Member

UPDATED: Implications for Hospitals and Health Systems During a Government Shutdown

Government funding and certain health care programs and waivers expired at midnight Sept. 30 as congressional leaders were unable to reach an agreement to keep the government funded.
Advisory
Member

Hospital Outpatient, Ambulatory Surgical Center Proposed Rule for CY 2026

The AHA is disappointed that CMS proposes an inadequate Medicare outpatient hospital payment update, as many hospitals — especially those in rural and underserved communities — operate under challenging financial pressures.
Advisory
Member

Trump Administration Issues Order on Drug Pricing

The White House April 15 released an executive order, “Lowering Drug Prices by Once Again Putting Americans First,” directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
Advisory
Member

CMS Finalizes Notice of Benefit and Payment Parameters for 2026

The Centers for Medicare & Medicaid Services (CMS) Jan. 13 released its standards for the health insurance marketplaces, including the issuers and brokers who assist marketplace enrollees, for 2026.